Gemcitabine and S-1 for Advanced Biliary Tract Cancer

NCT02146703 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Neoplasm

Interventions

DRUG: Gemcitabine, and S-1

Sponsor

Hallym University Medical Center

Collaborators

[object Object]